Fact CheckerSign in

NCT07304375Recruiting

Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis

Effects of Aerobic Exercise and Daytime Sleep on Neurorehabilitation and Functional Abilities in Multiple Sclerosis: Evidence of Training the Brain in Neurorehabilitation

Source: ClinicalTrials.gov · Last updated 8 Jan 2026

Brief summary (registry, in English)

The ExSiMS study is a randomized, controlled crossover study including 20 individuals (18-70 years) diagnosed with relapsing remitting Multiple Sclerosis (MS) This project investigates, through behavioral and neurophysiological measurements, how aerobic exercise on an ergometer bike and sleep in the form of a nap and overnight sleep may enhance cortical motor skill learning evaluated by a complex hand motor skill test and thereby improve functional capacity in individuals with MS. Beyond the effect on motor skill learning, the project investigate the effect on electroencephalography (EEG) - electromyography (EMG) coherence. The study hypothesizes that individuals with neurological conditions, such as multiple sclerosis (MS), may experience beneficial effects on specific motor rehabilitation through systematically planned cardiovascular exercise and sleep scheduling, due to positive impacts on memory consolidation. Aims: * Investigate the brain's neurophysiological responses and memory effects following a training intervention and, separately, sleep, in the form of a power nap, in individuals with MS. * Examine whether these effects persist beyond the few days previously observed in healthy individuals by implementing a longer-term intervention. * Explore whether the training effect is influenced by disease activity in the brain, such as during relapses and during immunosuppressive treatment. * Assess whether the presence of abnormally reduced cognitive endurance (fatigue) affects the impact of the intervention involving exercise and sleep. The study is based on documented positive effects of physical activity and sleep in both young and older adults, as well as in individuals recovering from stroke. The research thus offers promising perspectives for broader applications within neurorehabilitation, and particularly for MS, as the disease is associated with functional impairments. At the same time, both physical exercise and sleep represent meaningful interventions that should be thoughtfully integrated into rehabilitation strategies.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
26 Nov 2025
Start date
1 Dec 2025
Primary completion date
30 Aug 2028
Lead sponsor
Zealand University Hospital
NCT number
NCT07304375

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 1 Dec 2025 to the primary completion date, 30 Aug 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Epilepsy or neuromuscular diseases

Other

  • Implanted devices, such as pacemakers or stimulators

Who the study is looking for

  • Competent individuals (aged 18-70) diagnosed with early relapsing-remitting MS
  • Expanded Disability Status Score, 1 \< EDSS \< 4.5
  • MRC muscle strength ≥ 4+ in the dominant hand

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Section of Movement and Neuroscience, Department of Nutrition, Exercise, and Sports, University of Copenhagen
Coordinator of this site? Confirm its status
CopenhagenDenmarkNot yet recruiting
Zealand University Hospital, Roskilde
Coordinator of this site? Confirm its status
RoskildeDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.